#Portugal #Lisbon #Clinical AI #Ada Health #CUF

Transforming Patient Care Decisions with Ada Health's Clinical AI

In a recent study published in NEJM AI, a significant breakthrough was demonstrated by Ada Health, a pioneering company in clinical artificial intelligence. Conducted in partnership with CUF, the largest private healthcare network in Portugal, this study revealed that Ada's AI technology not only helps patients understand their symptoms but also guides them to make better healthcare decisions.

When confronted with unexplained health issues, patients often face uncertainty over whether to visit a primary care doctor, a specialist, or rush to emergency care. This indecision can result in delays in receiving the proper diagnosis, wasted time in the wrong healthcare settings, and sometimes even years of unnecessary suffering. Although AI tools have been introduced into healthcare to help mitigate these problems, previous evaluations have often been limited to theoretical scenarios, examining algorithm accuracy over actual changes in patient behavior or care appropriateness.

The ESSENCE study aimed to bridge this gap. It was designed to analyze real-world patient behavior by linking electronic health records with follow-up surveys and assessing care appropriateness through an independent panel of physicians. By moving beyond mere hypothetical cases, the study clearly documented how patients interacted with Ada's clinical intelligence to improve their healthcare navigation.

Dr. Fabienne Cotte, the first author of the study and advisor on clinical studies at Ada Health, remarked on the significance of these findings, stating, "For too long, the conversation about AI in healthcare has focused only on accuracy scores and theoretical potential. This study demonstrates that embedding Ada into real patient care journeys can transform their navigation through the health system. This sets a new benchmark for digital health tools."

Key Findings from the ESSENCE Study

The study enrolled 1,470 adults utilizing CUF's myCUF app, which integrates symptom assessments with direct care booking capabilities. Here are some of the essential insights uncovered:

1. Changes in Patient Behavior: After using Ada's assessment tools, one in three participants revised their intended course of action regarding their care level, drastically reducing uncertainty from 12.6% to just 5%.
2. Actual Care Decisions: Follow-up tracking indicated that nearly 60% of patients sought care in different settings than initially planned following their Ada assessment.
3. Improved Care Appropriateness: The percentage of patients receiving clinically appropriate care jumped from 29.8% to 64.4% after using Ada. Notably, among those who initially intended to go to an emergency department, about 40% redirected to a suitable lower-acuity facility, as confirmed by physician evaluations.

The study also monitored subsequent visits and hospitalizations through electronic health records without any safety concerns emerging.

Dr. Micaela Seemann Monteiro, the Chief Medical Officer for Digital Transformation at CUF, highlighted the value of these results, emphasizing that real-world healthcare innovation should showcase tangible benefits: "When patients receive timely and accurate guidance during uncertain moments, they not only make better choices but also navigate to the right care effectively. This has meaningful implications for patient outcomes."

A New Standard for Digital Health

What stands out in this study is the shift from merely assessing intent to actual patient actions. The study demonstrated that upon completion of an Ada assessment, patients were not only informed but also enabled to connect with the right services promptly. Instead of just managing demand through AI technologies, patients were effectively redirected toward the most appropriate care pathways. This lays down a new criterion by which AI healthcare tools should be evaluated—not just on engagement and accuracy, but significantly on real-world outcomes and patient behavior shifts.

About Ada Health

Ada Health is at the intersection of advanced clinical expertise and artificial intelligence, aiming to enhance understanding of symptoms for individuals and healthcare providers alike. Developed by a team comprising doctors, scientists, and engineers, Ada employs sophisticated algorithms to offer actionable insights, benefiting over 40 million assessments to date. Recognized in the European Union as a Class IIa medical device, Ada's technology is actively utilized by renowned health systems and insurance providers to optimize care pathways and improve health outcomes.

About CUF

With a legacy spanning eight decades, CUF is a pillar of private healthcare in Portugal. It operates an extensive integrated network of facilities offering comprehensive healthcare services. Renowned for its clinical quality and commitment to innovation, CUF caters to over 14% of Portugal's population, reflecting its dedication to positive public health outcomes.

The findings from the ESSENCE study herald a transformative step towards integrating AI into practical healthcare applications, paving the way for improved patient experiences and smarter health transitions.